EUVIMEDEUVIMED entdecken
Open Access

Effects of ketamine on GABAergic and glutamatergic activity in the mPFC: biphasic recruitment of GABA function in antidepressant-like responses

Manoela V Fogaça, Fernanda Daher, Marina R Picciotto

Neuropsychopharmacology · 2025-03 · 50 (4) · 673-684

DOI: 10.1038/s41386-024-02002-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropsychopharmacology, online erschienen am 11.10.2024. Verfasst von Manoela V Fogaça und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Physiology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA. manoela_fogaca@urmc…. Hauptthemen laut MEDLINE: Ketamine, Prefrontal Cortex, Antidepressive Agents, Glutamic Acid. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH), Brain and Behavior Research Foundation (Brain & Behavior Research Foundation).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Major depressive disorder (MDD) is associated with disruptions in glutamatergic and GABAergic activity in the medial prefrontal cortex (mPFC), leading to altered synaptic formation and function. Low doses of ketamine rapidly rescue these deficits, inducing fast and sustained antidepressant effects. While it is suggested that ketamine produces a rapid glutamatergic enhancement in the mPFC, the temporal dynamics and the involvement of GABA interneurons in its sustained effects remain unclear. Using simultaneous photometry recordings of calcium activity in mPFC pyramidal and GABA neurons, as well as chemogenetic approaches in Gad1-Cre mice, we explored the hypothesis that initial effects of ketamine on glutamate signaling trigger subsequent enhancement of GABAergic responses, contributing to its sustained antidepressant responses. Calcium recordings revealed a biphasic effect of ketamine on activity of mPFC GABA neurons, characterized by an initial transient decrease (phase 1, 60 min), in parallel with a transient increase in excitation/inhibition levels (10 min) and lasting enhancement of glutamatergic activity (30-120 min). Previous administration of ketamine enhanced GABA neuron activity during the sucrose splash test (SUST) and novelty suppressed feeding test (NSFT), 24 h and 72 h post-treatment, respectively. Chemogenetic inhibition of GABA interneurons during the surge of GABAergic activity (phase 2), or immediately before the SUST or NSFT, occluded ketamine's behavioral actions. These results indicate that time-dependent modulation of GABAergic activity is required for the sustained antidepressant-like responses induced by ketamine, suggesting that approaches to enhance GABAergic plasticity and function are promising therapeutic targets for antidepressant development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetaminePrefrontal CortexAntidepressive AgentsGlutamic Acidgamma-Aminobutyric AcidGABAergic NeuronsAnimalsMiceMaleMice, TransgenicMice, Inbred C57BLGlutamate DecarboxylasePyramidal CellsExcitatory Amino Acid Antagonists

Substanzen

KetamineAntidepressive AgentsGlutamic Acidgamma-Aminobutyric AcidGlutamate DecarboxylaseExcitatory Amino Acid Antagonists

Autor:innen und Institutionen

  • Department of Pharmacology and Physiology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA. manoela_fogaca@urmc.rochester.edu.
  • Department of Psychiatry, Yale University School of Medicine, 34 Park Street, New Haven, CT, 06519, USA. manoela_fogaca@urmc.rochester.edu.
  • Department of Pharmacology and Physiology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA.
  • Department of Psychiatry, Yale University School of Medicine, 34 Park Street, New Haven, CT, 06519, USA.

Förderung

  • NIMH NIH HHS
  • U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
  • Brain and Behavior Research Foundation (Brain & Behavior Research Foundation)

Zitieren

APA

Fogaça, M. V., Daher, F., & Picciotto, M. R. (2025). Effects of ketamine on GABAergic and glutamatergic activity in the mPFC: biphasic recruitment of GABA function in antidepressant-like responses. Neuropsychopharmacology, 50(4), 673-684. https://doi.org/10.1038/s41386-024-02002-1

Vancouver

Fogaça MV, Daher F, Picciotto MR. Effects of ketamine on GABAergic and glutamatergic activity in the mPFC: biphasic recruitment of GABA function in antidepressant-like responses. Neuropsychopharmacology. 2025;50(4):673-684. doi:10.1038/s41386-024-02002-1

BibTeX
@article{Fogaa2025,
  author = {Fogaça, Manoela V and Daher, Fernanda and Picciotto, Marina R},
  title = {Effects of ketamine on GABAergic and glutamatergic activity in the mPFC: biphasic recruitment of GABA function in antidepressant-like responses},
  journal = {Neuropsychopharmacology},
  year = {2025},
  volume = {50},
  number = {4},
  pages = {673--684},
  doi = {10.1038/s41386-024-02002-1}
}
Kostenlos starten →